Access
To read this story in full you will need to login or make a payment (see right).
News and Views
Nature 394, 527-528 (6 August 1998) | doi:10.1038/28961
Cancer: Proteases — invasion and more
Dylan R. Edwards1 & Gillian Murphy1
The June AACR/APMIS conference*on 'proteases and protease inhibitors in cancer' provided an opportunity to take a good look at the importance of these proteins in cancer biology, particularly for functions other than cellular invasion1. The conference came at an appropriate time, with booming interest in angiogenesis (the formation of new blood vessels) as a therapeutic target and with first-generation synthetic matrix metalloproteinase inhibitors (MMPIs), such as British Biotech's marimastat, hitting the clinic.
To read this story in full you will need to login or make a payment (see right).
